Efficacy and Safety of AQX-1125 in Unstable COPD
Clinical trial NCT01954628 · COMPLETED
Trial details
- NCT number
- NCT01954628
- Sponsor
- Aquinox Pharmaceuticals (Canada) Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-07-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.